Under 30 forfattere

Oppdatert 30. mars 2017

1. Acquavella J, Ehrenstein V, Schiodt M, Heide-Jorgensen U, Kjellman A, Hansen S, Larsson Wexell C, Herlofson BB, Noerholt SE, Ma H, Ohrling K, Hernandez RK, Sorensen HT. Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events. Clin Epidemiol. 2016;8:267-72. doi:http://dx.doi.org/10.2147/clep.s107270

2. Adel Fahmideh M, Lavebratt C, Schuz J, Roosli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M. Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility. Oncotarget. 2016. doi:http://dx.doi.org/10.18632/oncotarget.11575

3. Alfonso JH, Martinsen JI, Pukkala E, Weiderpass E, Tryggvadottir L, Nordby KC, Kjaerheim K. Occupation and relative risk of cutaneous squamous cell carcinoma (cSCC): A 45-year follow-up study in 4 Nordic countries. J Am Acad Dermatol. 2016;75(3):548-55. doi:http://dx.doi.org/10.1016/j.jaad.2016.03.033

4. Andreassen BK, Aagnes B, Gislefoss R, Andreassen M, Wahlqvist R. Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014. BMC Cancer. 2016;16(1):799. doi:http://dx.doi.org/http://dx.doi.org/ 10.1186/s12885-016-2832-x

5. Antoni S, Soerjomataram I, Moller B, Bray F, Ferlay J. An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bull World Health Organ. 2016;94(3):174-84. doi:http://dx.doi.org/10.2471/BLT.15.164384

6. Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Holmqvist AS, Malila N, Tryggvadottir L, Wesenberg F, Dahlerup JF, Olsen JH, Hasle H, on behalf of the Asg. Gastrointestinal and liver disease in Adult Life After Childhood Cancer in Scandinavia: A population-based cohort study. Int J Cancer. 2016;139(7):1501-11. doi:http://dx.doi.org/10.1002/ijc.30198

7. Babaei M, Balavarca Y, Jansen L, Gondos A, Lemmens V, Sjövall A, Johannesen TB, Moreau M, Gabriel L, Gonçalves AF, Bento MJ, Van De Velde T, Kempfer LR, Becker N, Ulrich A, Ulrich CM, Schrotz-King P, Brenner H. Minimally invasive colorectal cancer surgery in Europe. Medicine (Baltimore). 2016;95(22):e3812. doi:http://dx.doi.org/10.1097/MD.0000000000003812

8. Bains SJ, Mahic M, Myklebust TA, Smastuen MC, Yaqub S, Dorum LM, Bjornbeth BA, Moller B, Brudvik KW, Tasken K. Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study. J Clin Oncol. 2016. doi:http://dx.doi.org/10.1200/jco.2015.65.3519

9. Berstad P, Botteri E, Larsen IK, Loberg M, Kalager M, Holme O, Bretthauer M, Hoff G. Lifestyle changes at middle age and mortality: a population-based prospective cohort study. J Epidemiol Community Health. 2016. doi:http://dx.doi.org/10.1136/jech-2015-206760

10. Bjorge T, Gissler M, Ording AG, Engeland A, Glimelius I, Leinonen M, Sorensen HT, Tretli S, Ekbom A, Troisi R, Grotmol T. Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study. Br J Cancer. 2016;115(11):1416-20. doi:http://dx.doi.org/http://dx.doi.org/ 10.1038/bjc.2016.315

11. Bjorge T, Skare GB, Bjorge L, Trope A, Lonnberg S. Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia. Obstet Gynecol. 2016;128(6):1265-73. doi:http://dx.doi.org/http://dx.doi.org/10.1097/aog.0000000000001777

12. Björkblom B, Wibom C, Jonsson P, Mörén L, Andersson U, Børge Johannesen T, Langseth H, Antti H, Melin B. Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk. Oncotarget. 2016.

13. Bonnesen TG, Winther JF, Asdahl PH, De Fine Licht S, Gudmundsdottir T, Sällfors Holmqvist A, Madanat-Harjuoja LM, Tryggvadottir L, Wesenberg F, Birn H, Olsen JH, Hasle H. Long-term risk of renal and urinary tract diseases in childhood cancer survivors: A population-based cohort study. Eur J Cancer. 2016;64:52-61. doi:http://dx.doi.org/10.1016/j.ejca.2016.05.006

14. Brelin S, Fredheim OM, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ. Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study. Journal of opioid management. 2016;12(1):25-36. doi:http://dx.doi.org/10.5055/jom.2016.0309

15. Bryk S, Pukkala E, Martinsen JI, Unkila-Kallio L, Tryggvadottir L, Sparen P, Kjaerheim K, Weiderpass E, Riska A. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953-2012: a longitudinal cohort study. BJOG. 2016. doi:http://dx.doi.org/10.1111/1471-0528.13949

16. Burger EA, Sy S, Nygard M, Kim JJ. The cost-effectiveness of cervical self-sampling to improve routine cervical cancer screening: The importance of respondent screening history and compliance. Cancer Epidemiol Biomarkers Prev. 2016. doi:http://dx.doi.org/10.1158/1055-9965.epi-16-0350

17. Castells X, Tora-Rocamora I, Posso M, Roman M, Vernet-Tomas M, Rodriguez-Arana A, Domingo L, Vidal C, Bare M, Ferrer J, Quintana MJ, Sanchez M, Natal C, Espinas JA, Saladie F, Sala M. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features. Radiology. 2016:151174. doi:http://dx.doi.org/10.1148/radiol.2016151174

18. Christiansen JR, Massey R, Dalen H, Kanellopoulos A, Hamre H, Fossa SD, Ruud E, Kiserud CE, Aakhus S. Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia. Am J Cardiol. 2016. doi:http://dx.doi.org/10.1016/j.amjcard.2016.05.021

19. Christiansen JR, Massey R, Dalen H, Kanellopoulos A, Hamre H, Ruud E, Kiserud CE, Fossa SD, Aakhus S. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia. Eur Heart J Cardiovasc Imaging. 2016. doi:http://dx.doi.org/10.1093/ehjci/jew018

20. Dale JE, Sebjornsen S, Leh S, Rosler C, Aaserud S, Moller B, Fluge O, Erichsen C, Nadipour S, Korner H, Pfeffer F, Dahl O. Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncol. 2016;56(1):1-7. doi:http://dx.doi.org/10.1080/0284186x.2016.1244356

21. Das MK, Andreassen R, Haugen TB, Furu K. Identification of Endogenous Controls for Use in miRNA Quantification in Human Cancer Cell Lines. Cancer Genomics Proteomics. 2016;13(1):63-8.

22. Enerly E, Bonde J, Schee K, Pedersen H, Lönnberg S, Nygård M. Self-sampling for human papillomavirus testing among non-attenders increases attendance to the norwegian cervical cancer screening programme. PLoS One. 2016;11(4). doi:http://dx.doi.org/10.1371/journal.pone.0151978

23. Engesaeter B, van Diermen Hidle B, Hansen M, Moltu P, Staby KM, Borchgrevink-Persen S, Vintermyr OK, Lonnberg S, Nygard M, Janssen EA, Castle PE, Christiansen IK. Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study. BMC Infect Dis. 2016;16(1):698. doi:http://dx.doi.org/10.1186/s12879-016-2028-7

24. Eskeland SL, Brunborg C, Seip B, Wiencke K, Hovde O, Owen T, Skogestad E, Huppertz-Hauss G, Halvorsen FA, Garborg K, Aabakken L, de Lange T. First quality score for referral letters in gastroenterology-a validation study. BMJ open. 2016;6(10):e012835. doi:http://dx.doi.org/http://dx.doi.org/ 10.1136/bmjopen-2016-012835

25. Falk RS, Hofvind S. Over-diagnosis in mammographic screening due to competing risk of death. Cancer Epidemiol Biomarkers Prev. 2016;25(5):759-65. doi:http://dx.doi.org/10.1158/1055-9965.epi-15-0819

26. Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J. Cutaneous Human Papillomaviruses and squamous cell carcinoma of the skin: Nested case-control study. Cancer Epidemiol Biomarkers Prev. 2016;25(4):721-4. doi:http://dx.doi.org/10.1158/1055-9965.epi-15-1290

27. Figueiredo RA, Weiderpass E, Tajara EH, Strom P, Carvalho AL, de Carvalho MB, Kanda JL, Moyses RA, Wunsch-Filho V. Diabetes mellitus, metformin and head and neck cancer. Oral Oncol. 2016;61:47-54. doi:http://dx.doi.org/http://dx.doi.org/ 10.1016/j.oraloncology.2016.08.006

28. Fjeldheim FN, Frydenberg H, Flote VG, McTiernan A, Furberg AS, Ellison PT, Barrett ES, Wilsgaard T, Jasienska G, Ursin G, Wist EA, Thune I. Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes. BMC Cancer. 2016;16(1):776. doi:http://dx.doi.org/http://dx.doi.org/ 10.1186/s12885-016-2804-1

29. Fossa SD, Storas AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA. Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26). Scandinavian journal of urology. 2016:1-6. doi:http://dx.doi.org/10.3109/21681805.2016.1163617

30. Fossa SD, Wiklund F, Klepp O, Angelsen A, Solberg A, Damber J-E, Hoyer M, Widmark A. Ten- and 15-yr prostate cancer-specific mortality in patients with nonmetastatic locally advanced or aggressive intermediate prostate cancer, randomized to lifelong endocrine treatment alone or combined with radiotherapy: final results of The Scandinavian Prostate Cancer Group-7. Eur Urol. 2016;70(4):684-91. doi:http://dx.doi.org/http://dx.doi.org10.1016/j.eururo.2016.03.021

31. Fossum S, Vikanes AV, Naess O, Vos L, Grotmol T, Halvorsen S. Hyperemesis gravidarum and long-term mortality: a population-based cohort study. BJOG. 2016. doi:http://dx.doi.org/10.1111/1471-0528.14454

32. Fredheim OM, Brelin S, Hjermstad MJ, Loge JH, Aass N, Johannesen TB, Skurtveit S. Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009. Eur J Pain. 2016. doi:http://dx.doi.org/http://dx.doi.org/ 10.1002/ejp.956

33. Gaudet MM, Barrdahl M, Lindstrom S, Travis RC, Auer PL, Buring JE, Chanock SJ, Eliassen AH, Gapstur SM, Giles GG, Gunter M, Haiman C, Hunter DJ, Joshi AD, Kaaks R, Khaw KT, Lee IM, Le Marchand L, Milne RL, Peeters PH, Sund M, Tamimi R, Trichopoulou A, Weiderpass E, Yang XR, Prentice RL, Feigelson HS, Canzian F, Kraft P. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Res Treat. 2016;155(3):531-40. doi:http://dx.doi.org/10.1007/s10549-016-3681-7

34. Gervin K, Kulle B, Hjorthaug HS, Carlsen KCL, Carlsen K-H, Undlien DE, Lyle R, Munthe-Kaas MC. Intra-individual changes in DNA methylation not mediated by cell-type composition are correlated with aging during childhood. Clin Epigenetics. 2016;8:110:1-12. doi:http://dx.doi.org/http://dx.doi.org10.1186/s13148-016-0277-3

35. Gervin K, Page CM, Aass HC, Jansen MA, Fjeldstad HE, Andreassen BK, Duijts L, van Meurs JB, van Zelm MC, Jaddoe VW, Nordeng H, Knudsen GP, Magnus P, Nystad W, Staff AC, Felix JF, Lyle R. Cell type specific DNA methylation in cord blood: A 450K-reference data set and cell count-based validation of estimated cell type composition. Epigenetics. 2016;11(9):690-8. doi:http://dx.doi.org/10.1080/15592294.2016.1214782

36. Ghiasvand R, Weiderpass E, Green AC, Lund E, Veierod MB. Sunscreen Use and Subsequent Melanoma Risk: A Population-Based Cohort Study. J Clin Oncol. 2016;34(33):3976-83. doi:http://dx.doi.org/10.1200/jco.2016.67.5934

37. Gislefoss RE, Lauritzen M, Langseth H, Morkrid L. Effect of multiple freeze-thaw cycles on selected biochemical serum components. Clin Chem Lab Med. 2016. doi:http://dx.doi.org/10.1515/cclm-2016-0892

38. Glimelius B, Myklebust TÅ, Lundquist K, Wibe A, Guren M. Two countries – Two treatment strategies for rectal cancer. Radiother Oncol. 2016;121(3):357-63. doi:http://dx.doi.org/http://dx.doi.org10.1016/j.radonc.2016.11.010

39. Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johansson U, Tvedskov TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgeois P, Moreau M, Matrai Z, Savolt A, Nagy P, Kasler M, Schrotz-King P, Ulrich C, Brenner H. Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers. Acta Oncol. 2016;55(6):1-8. doi:http://dx.doi.org/10.3109/0284186x.2015.1136751

40. Grell K, Frederiksen K, Schuz J, Cardis E, Armstrong B, Siemiatycki J, Krewski DR, McBride ML, Johansen C, Auvinen A, Hours M, Blettner M, Sadetzki S, Lagorio S, Yamaguchi N, Woodward A, Tynes T, Feychting M, Fleming SJ, Swerdlow AJ, Andersen PK. The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study. Am J Epidemiol. 2016. doi:http://dx.doi.org/10.1093/aje/kww082

41. Gunnes MW, Lie RT, Bjorge T, Ghaderi S, Ruud E, Syse A, Moster D. Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study. Br J Cancer. 2016;114(3):348-56. doi:http://dx.doi.org/10.1038/bjc.2015.455

42. Gunnes MW, Lie RT, Bjørge T, Ghaderi S, Syse A, Ruud E, Wesenberg F, Moster D. Suicide and violent deaths in survivors of cancer in childhood, adolescence and young adulthood-a national cohort study. Int J Cancer. 2016;140(3):575-80. doi:http://dx.doi.org/http://dx.doi.org10.1002/ijc.30474

43. Gunnes MW, Lie RT, Bjørge T, Syse A, Ruud E, Wesenberg F, Moster D. Economic independence in survivors of cancer diagnosed at a young age: A Norwegian national cohort study. Cancer. 2016;122(24):3873-82. doi:http://dx.doi.org/http://dx.doi.org10.1002/cncr.30253

44. Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Pukkala E. Occupation and Risk of Bladder Cancer in Nordic Countries. J Occup Environ Med. 2016;58(8):e301-7. doi:http://dx.doi.org/10.1097/jom.0000000000000803

45. Hansen BT. No evidence that HPV vaccination leads to sexual risk compensation. Hum Vaccin Immunother. 2016;12(6):1451-3. doi:http://dx.doi.org/10.1080/21645515.2016.1158367

46. Hauptmann M, Johannesen TB, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Jr., Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB. Increased pancreatic cancer risk following radiotherapy for testicular cancer. Br J Cancer. 2016. doi:http://dx.doi.org/10.1038/bjc.2016.272

47. Hedelin M, Lof M, Sandin S, Adami HO, Weiderpass E. Prospective Study of Dietary Phytoestrogen Intake and the Risk of Colorectal Cancer. Nutr Cancer. 2016;68(3):388-95. doi:http://dx.doi.org/10.1080/01635581.2016.1152380

48. Heir T, Falk RS, Robsahm TE, Sandvik L, Erikssen J, Tretli S. Cholesterol and prostate cancer risk: a long-term prospective cohort study. BMC Cancer. 2016;16:643. doi:http://dx.doi.org/10.1186/s12885-016-2691-5

49. Helgeland J, Kristoffersen DT, Skyrud KD, Lindman AS. Variation between Hospitals with Regard to Diagnostic Practice, Coding Accuracy, and Case-Mix. A Retrospective Validation Study of Administrative Data versus Medical Records for Estimating 30-Day Mortality after Hip Fracture. PLoS One. 2016;11(5):e0156075. doi:http://dx.doi.org/10.1371/journal.pone.0156075

50. Helsing P, Robsahm TE, Vos L, Rizvi SM, Akslen LA, Veierod MB. Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location. J Am Acad Dermatol. 2016. doi:http://dx.doi.org/10.1016/j.jaad.2016.06.048

51. Hjelle KM, Johannesen TB, Beisland C. Postoperative 30-day Mortality Rates for Kidney Cancer Are Dependent on Hospital Surgical Volume: Results from a Norwegian Population-based Study. European Urology Focus. 2016. doi:http://dx.doi.org/http://dx.doi.org10.1016/j.euf.2016.10.001

52. Hjelle LV, Bremnes RM, Gundersen PO, Sprauten M, Brydoy M, Tandstad T, Wilsgaard T, Fossa SD, Oldenburg J, Haugnes HS. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors. Urol Oncol. 2016. doi:http://dx.doi.org/10.1016/j.urolonc.2016.06.012

53. Hofvind S, Bennett RL, Brisson J, Lee W, Pelletier E, Flugelman A, Geller B. Audit feedback on reading performance of screening mammograms: An international comparison. J Med Screen. 2016;23(3):150-9. doi:http://dx.doi.org/10.1177/0969141315610790

54. Hofvind S, Roman M, Sebuodegard S, Falk RS. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program. J Med Screen. 2016. doi:http://dx.doi.org/10.1177/0969141315625088

55. Holme O, de Lange T, Stallemo A, Wiig H, Hasund A, Dvergsnes K, Garborg K, Ystrom CM, Loberg M, Hoff G, Bretthauer M, Kalager M. Routine vs. on-demand analgesia in colonoscopy: a randomized clinical trial. Endoscopy. 2016. doi:http://dx.doi.org/10.1055/s-0042-108433

56. Hwang Y, Lee KE, Weiderpass E, Park YJ, Chai YJ, Kwon H, Park do J, Cho B, Choi HC, Kang D, Park SK. Acute High-Dose and Chronic Lifetime Exposure to Alcohol Consumption and Differentiated Thyroid Cancer: T-CALOS Korea. PLoS One. 2016;11(3):e0151562. doi:http://dx.doi.org/10.1371/journal.pone.0151562

57. Jover R, Bretthauer M, Dekker E, Holme O, Kaminski MF, Loberg M, Zauber AG, Hernan MA, Lansdorp-Vogelaar I, Sunde A, McFadden E, Castells A, Regula J, Quintero E, Pellise M, Senore C, Kalager M, Dinis-Ribeiro M, Emilsson L, Ransohoff DF, Hoff G, Adami HO. Rationale and design of the European Polyp Surveillance (EPoS) trials. Endoscopy. 2016. doi:http://dx.doi.org/10.1055/s-0042-104116

58. Kirkoen B, Berstad P, Botteri E, Avitsland TL, Ossum AM, de Lange T, Hoff G, Bernklev T. Do no harm: no psychological harm from colorectal cancer screening. Br J Cancer. 2016;114(5):497-504. doi:http://dx.doi.org/10.1038/bjc.2016.14

59. Kirkoen B, Berstad P, Botteri E, Bernklev L, El-Safadi B, Hoff G, de Lange T, Bernklev T. Psychological effects of colorectal cancer screening: Participants vs individuals not invited. World J Gastroenterol. 2016;22(43):9631-41. doi:http://dx.doi.org/10.3748/wjg.v22.i43.9631

60. Knudsen MD, de Lange T, Botteri E, Nguyen DH, Evensen H, Steen CB, Hoff G, Bernklev T, Hjartaker A, Berstad P. Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia. World J Gastroenterol. 2016;22(27):6276-86. doi:http://dx.doi.org/10.3748/wjg.v22.i27.6276

61. Knudsen MD, Hjartaker A, Olsen MK, Hoff G, Lange TD, Bernklev T, Berstad P. Changes in health behavior 1 year after testing negative at a colorectal cancer screening: a randomized-controlled study. Eur J Cancer Prev. 2016. doi:http://dx.doi.org/10.1097/cej.0000000000000328

62. Kvammen O, Myklebust TA, Solberg A, Moller B, Klepp OH, Fossa SD, Tandstad T. Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor. Cancer Epidemiol Biomarkers Prev. 2016;25(5):773-9. doi:http://dx.doi.org/10.1158/1055-9965.epi-15-1153

63. Laake I, Larsen IK, Selmer R, Thune I, Veierod MB. Pre-diagnostic body mass index and weight change in relation to colorectal cancer survival among incident cases from a population-based cohort study. BMC Cancer. 2016;16:402. doi:http://dx.doi.org/10.1186/s12885-016-2445-4

64. Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G. Cohort Profile: The Janus Serum Bank Cohort in Norway. Int J Epidemiol. 2016. doi:http://dx.doi.org/10.1093/ije/dyw027

65. Lassemo E, Sandanger I, Nygard JF, Sorgaard KW. The epidemiology of post-traumatic stress disorder in Norway: trauma characteristics and pre-existing psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol. 2016. doi:http://dx.doi.org/http://dx.doi.org/10.1007/s00127-016-1295-3

66. Leinonen MK, Campbell S, Klungsoyr O, Lonnberg S, Hansen BT, Nygard M. Personal and provider level factors influence participation to cervical cancer screening: A retrospective register-based study of 1.3 million women in Norway. Prev Med. 2016. doi:http://dx.doi.org/10.1016/j.ypmed.2016.11.018

67. Lenartova A, Johannesen TB, Tjonnfjord GE. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data. Cancer medicine. 2016;5(12):3588-95. doi:http://dx.doi.org/10.1002/cam4.849

68. Licaj I, Jacobsen BK, Selmer RM, Maskarinec G, Weiderpass E, Gram IT. Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women. Br J Cancer. 2016. doi:http://dx.doi.org/10.1038/bjc.2016.418

69. Licaj I, Sandin S, Skeie G, Adami HO, Roswall N, Weiderpass E. Alcohol consumption over time and mortality in the Swedish Women's Lifestyle and Health cohort. BMJ open. 2016;6(11):e012862. doi:http://dx.doi.org/10.1136/bmjopen-2016-012862

70. Lorentzen JA, Grzyb K, De Angelis PM, Hoff G, Eide TJ, Andresen PA. Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study. Clin Med Insights Pathol. 2016;9(1):19-28. doi:http://dx.doi.org/10.4137/CPath.s40143

71. Lousdal ML, Kristiansen IS, Moller B, Stovring H. Effect of organised mammography screening on stage-specific incidence in Norway: population study. Br J Cancer. 2016;114(5):590-6. doi:http://dx.doi.org/10.1038/bjc.2016.8

72. Lousdal ML, Kristiansen IS, Moller B, Stovring H. Predicting Mean Survival Time from Reported Median Survival Time for Cancer Patients. Med Decis Making. 2016. doi:http://dx.doi.org/10.1177/0272989x16655341

73. Lukic M, Jareid M, Weiderpass E, Braaten T. Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study. BMC Cancer. 2016;16(1):562. doi:http://dx.doi.org/10.1186/s12885-016-2586-5

74. Lukic M, Licaj I, Lund E, Skeie G, Weiderpass E, Braaten T. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol. 2016. doi:http://dx.doi.org/10.1007/s10654-016-0142-x

75. Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J. Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer. Acta Oncol. 2016;55(7):389-45. doi:http://dx.doi.org/10.3109/0284186x.2016.1139178

76. Luxembourg A, Kjaer SK, Nygard M, Ellison MC, Group T, Marshall JB, Radley D, Saah A. Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine. Contemp Clin Trials. 2016. doi:http://dx.doi.org/http://dx.doi.org/10.1016/j.cct.2016.10.006

77. Løkeland M, Bjørge T, Iversen O-E, Akerkar R, Bjørge L. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013. Int J Epidemiol. 2016. doi:http://dx.doi.org/http://dx.doi.org10.1093/ije/dyw270

78. Lönnberg S, Andreassen T, Engesæter BØ, Lilleng R, Kleven C, Skare A, Johansson K, Fredheim CS, Trope A. Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention. BMJ open. 2016;6(11):e013728. doi:http://dx.doi.org/http://dx.doi.org10.1136/bmjopen-2016-013728

79. Maatta S, Nuutinen T, Ray C, Eriksson JG, Weiderpass E, Roos E. Validity of self-reported out-of-school physical activity among Finnish 11-year-old children. Archives of public health = Archives belges de sante publique. 2016;74:11. doi:http://dx.doi.org/10.1186/s13690-016-0123-2

80. Majidi A, Ghiasvand R, Hadji M, Nahvijou A, Mousavi A-S, Pakgohar M, Khodakarami N, Abedini M, Hashemi FA, Farzami MR, Shahsiah R, Sajedinejhad S, Mohagheghi MA, Nadali F, Rashidian A, Weiderpass E, Mogensen O, Zendehdel K. Priority setting for improvement of cervical cancer prevention in Iran. International Journal of Health Policy and Management. 2016;5(4):225-32. doi:http://dx.doi.org/http://dx.doi.org10.15171/ijhpm.2015.201

81. Malhotra J, Waterboer T, Pawlita M, Michel A, Cai Q, Zheng W, Gao YT, Lan Q, Rothman N, Langseth H, Grimsrud TK, Yuan JM, Koh WP, Wang R, Arslan AA, Zeleniuch-Jacquotte A, Boffetta P. Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers. Br J Cancer. 2016;115(9):1131-9. doi:http://dx.doi.org/10.1038/bjc.2016.285

82. Markussen MS, Veierod MB, Kristiansen AL, Ursin G, Andersen LF. Dietary patterns of women aged 50-69 years and associations with nutrient intake, sociodemographic factors and key risk factors for non-communicable diseases. Public Health Nutr. 2016:1-9. doi:http://dx.doi.org/10.1017/s1368980015003547

83. Markussen MS, Veierod MB, Ursin G, Andersen LF. The effect of under-reporting of energy intake on dietary patterns and on the associations between dietary patterns and self-reported chronic disease in women aged 50-69 years. Br J Nutr. 2016:1-12. doi:http://dx.doi.org/10.1017/s000711451600218x

84. McKenzie F, Biessy C, Ferrari P, Freisling H, Rinaldi S, Chajes V, Dahm CC, Overvad K, Dossus L, Lagiou P, Trichopoulos D, Trichopoulou A, Bas Bueno-De-Mesquita H, May A, Peeters PH, Weiderpass E, Sanchez M-J, Navarro C, Ardanaz E, Ericson U, Wirfalt E, Travis RC, Romieu I. Healthy lifestyle and risk of cancer in the European prospective investigation into cancer and nutrition cohort study. Medicine (Baltimore, Md). 2016;95(16). doi:http://dx.doi.org/10.1097/MD.0000000000002850

85. Meyer HE, Stoer NC, Samuelsen SO, Blomhoff R, Robsahm TE, Brustad M, Giovannucci EL, Bjorge T. Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men. PLoS One. 2016;11(3):e0151441. doi:http://dx.doi.org/10.1371/journal.pone.0151441

86. Moritz V, Holme O, Leblanc M, Hoff G. An explorative study from the Norwegian Quality Register Gastronet comparing self-estimated versus registered quality in colonoscopy performance. Endoscopy international open. 2016;4(3):E326-32. doi:http://dx.doi.org/10.1055/s-0042-100904

87. Mortensen JHS, Øyen N, Fomina T, Melbye M, Tretli S, Vollset SE, Bjørge T. Supplemental folic acid in pregnancy and childhood cancer risk. Br J Cancer. 2016;114:71-5. doi:http://dx.doi.org/http://dx.doi.org/10.1038/bjc.2015.446

88. Myklebust TA, Aagnes B, Moller B. An empirical comparison of methods for predicting net survival. Cancer Epidemiol. 2016;42:133-9. doi:http://dx.doi.org/10.1016/j.canep.2016.04.006

89. Plato N, Martinsen JI, Sparen P, Hillerdal G, Weiderpass E. Occupation and mesothelioma in Sweden. Updated incidence for men and women up to 27 years after asbestos ban. Epidemiology and health. 2016. doi:http://dx.doi.org/10.4178/epih.e2016039

90. Reigstad MM, Larsen IK, Myklebust TA, Robsahm TE, Oldereid NB, Brinton LA, Storeng R. Risk of Cancer in Children Conceived by Assisted Reproductive Technology. Pediatrics. 2016;137(3):1-12. doi:http://dx.doi.org/10.1542/peds.2015-2061

91. Rizzi S, Thinggaard M, Engholm G, Christensen N, Johannesen TB, Vaupel JW, Lindahl-Jacobsen R. Comparison of non-parametric methods for ungrouping coarsely aggregated data. BMC Med Res Methodol. 2016;16(1):59. doi:http://dx.doi.org/10.1186/s12874-016-0157-8

92. Robsahm TE, Falk RS, Heir T, Sandvik L, Vos L, Erikssen JE, Tretli S. Measured cardiorespiratory fitness and self-reported physical activity: associations with cancer risk and death in a long-term prospective cohort study. Cancer medicine. 2016. doi:http://dx.doi.org/10.1002/cam4.773

93. Roman M, Castells X, Hofvind S, von Euler-Chelpin M. Risk of breast cancer after false-positive results in mammographic screening. Cancer medicine. 2016;5(6):1298-306. doi:http://dx.doi.org/10.1002/cam4.646

94. Roman M, Graff-Iversen S, Weiderpass E, Vangen S, Sakshaug S, Hofvind S, Ursin G. Postmenopausal hormone therapy and breast cancer prognostic characteristics. A linkage between nation-wide registries. Cancer Epidemiol Biomarkers Prev. 2016;25(11):1464-73. doi:http://dx.doi.org/10.1158/1055-9965.epi-16-0240

95. Ronning PA, Helseth E, Meling TR, Johannesen TB. The effect of pregnancy on survival in a low-grade glioma cohort. J Neurosurg. 2016:1-8. doi:http://dx.doi.org/10.3171/2015.6.jns15985

96. Roswall N, Li Y, Sandin S, Strom P, Adami HO, Weiderpass E. Changes in body mass index and waist circumference and concurrent mortality among Swedish women. Obesity (Silver Spring, Md). 2016. doi:http://dx.doi.org/http://dx.doi.org/ 10.1002/oby.21675

97. Rounge TB, Page CM, Lepisto M, Ellonen P, Andreassen BK, Weiderpass E. Genome-wide DNA methylation in saliva and body size of adolescent girls. Epigenomics. 2016;8(11):1495-505. doi:http://dx.doi.org/http://dx.doi.org/10.2217/epi-2016-0045

98. Sarkkola C, Rounge TB, Simola-Strom S, von Kraemer S, Roos E, Weiderpass E. Validity of home-measured height, weight and waist circumference among adolescents. Eur J Public Health. 2016. doi:http://dx.doi.org/10.1093/eurpub/ckw133

99. Sebuodegard S, Sagstad S, Hofvind S. [Attendance in the Norwegian Breast Cancer Screening Programme]. Tidsskr Nor Laegeforen. 2016;136(17):1448-51. doi:http://dx.doi.org/10.4045/tidsskr.15.1013

100. Solvang HK, Frigessi A, Kaveh F, Riis MLH, Lüders T, Bukholm IRK, Kristensen VN, Andreassen BK. Gene expression analysis supports tumor threshold over 2.0 cm for T-category breast cancer. Eurasip Journal on Bioinformatics and Systems Biology. 2016;2016(1):1-11. doi:http://dx.doi.org/10.1186/s13637-015-0034-5

101. Sormunen J, Talibov M, Martinsen JI, Kjaerheim K, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E. Perceived physical strain at work and incidence of colorectal cancer: A nested case-control study. Cancer Epidemiol. 2016;43:100-4. doi:http://dx.doi.org/10.1016/j.canep.2016.07.001

102. Spath F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Bjorkblom B, Wibom C, Melin B. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumour Biol. 2016;37(8):11065-72. doi:http://dx.doi.org/10.1007/s13277-015-4742-y

103. Stenehjem JS, Smeland KB, Murbraech K, Holte H, Kvaloy S, Thorsen L, Arbo I, Jones LW, Aakhus S, Lund MB, Kiserud CE. Cardiorespiratory fitness in long-term lymphoma survivors after high-dose chemotherapy with autologous stem cell transplantation. Br J Cancer. 2016. doi:http://dx.doi.org/10.1038/bjc.2016.180

104. Stornes T, Wibe A, Nesbakken A, Myklebust TA, Endreseth BH. National early rectal cancer treatment revisited. Dis Colon Rectum. 2016;59(7):623-9. doi:http://dx.doi.org/10.1097/DCR.0000000000000591

105. Strand LA, Martinsen JI, Borud EK. Disease-related mortality among 21,609 Norwegian male military peacekeepers deployed to Lebanon between 1978 and 1998. Ann Epidemiol. 2016;26(10):693-7. doi:http://dx.doi.org/10.1016/j.annepidem.2016.08.005

106. Szczesny W, Vistad I, Kaern J, Nakling J, Trope C, Paulsen T. Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival. Eur J Gynaecol Oncol. 2016;37(3):305-11.

107. Tettamanti G, Shu X, Adel Fahmideh M, Schuz J, Roosli M, Tynes T, Grotzer MA, Johansen C, Klaeboe L, Kuehni CE, Lannering B, Samso Schmidt L, Vienneau D, Feychting M. Prenatal and postnatal medical conditions and the risk of brain tumors in children and adolescents: an international multicenter case-control study. Cancer Epidemiol Biomarkers Prev. 2016. doi:http://dx.doi.org/10.1158/1055-9965.epi-16-0451

108. Thomsen LT, Nygard M, Stensen S, Terning Hansen B, Arnheim Dahlstrom L, Liaw KL, Munk C, Kjaer SK. Awareness of human papillomavirus after introduction of HPV vaccination: a large population-based survey of Scandinavian women. Eur J Cancer Prev. 2016. doi:http://dx.doi.org/10.1097/cej.0000000000000238

109. Togawa K, Le Cornet C, Feychting M, Tynes T, Pukkala E, Hansen J, Olsson A, Oksbjerg Dalton S, Nordby KC, Uuksulainen S, Wiebert P, Woldbaek T, Skakkebaek NE, Fervers B, Schuz J. Parental occupational exposure to heavy metals and welding fumes and risk of testicular germ cell tumors in offspring: a registry-based case-control study. Cancer Epidemiol Biomarkers Prev. 2016;25(10):1426-34. doi:http://dx.doi.org/10.1158/1055-9965.epi-16-0328

110. Valberg M, Grotmol T, Tretli S, Veierod MB, Moger TA, Devesa SS, Aalen OO. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals? Eur J Epidemiol. 2016. doi:http://dx.doi.org/10.1007/s10654-016-0185-z

111. van Luijt PA, Heijnsdijk EA, van Ravesteyn NT, Hofvind S, de Koning HJ. Breast cancer incidence trends in Norway and estimates of overdiagnosis. J Med Screen. 2016. doi:http://dx.doi.org/http://dx.doi.org/10.1177/0969141316668379

112. Vandraas K, Tjonnfjord GE, Johannesen TB, Brandal P. Persistent bone marrow depression following short-term treatment with temozolomide. BMJ Case Rep. 2016;2016. doi:http://dx.doi.org/10.1136/bcr-2016-215797

113. Vigeland MD, Gjotterud KS, Selmer KK. FILTUS: a desktop GUI for fast and efficient detection of disease-causing variants, including a novel autozygosity detector. Bioinformatics. 2016;32(10):1592-4. doi:http://dx.doi.org/10.1093/bioinformatics/btw046

114. Vuong K, Armstrong BK, Weiderpass E, Lund E, Adami HO, Veierod MB, Barrett JH, Davies JR, Bishop DT, Whiteman DC, Olsen CM, Hopper JL, Mann GJ, Cust AE, McGeechan K. Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors. JAMA dermatology. 2016;152(8):889-96. doi:http://dx.doi.org/10.1001/jamadermatol.2016.0939

115. Waade GG, Highnam R, Hauge IHR, McEntee MF, Hofvind S, Denton E, Kelly J, Sarwar JJ, Hogg P. Impact of errors in recorded compressed breast thickness measurements on volumetric density classification using volpara v1.5.0 software. Med Phys. 2016;43(6):2870-6. doi:http://dx.doi.org/10.1118/1.4948503

116. Waade GG, Hofvind S, Thompson J, Highnam R, Hogg P. Development of a phantom to test fully automated breast density software – A work in progress. Radiography. 2016;23(1):e14-e9. doi:http://dx.doi.org/http://dx.doi.orgdx.doi.org/10.1016/j.radi.2016.09.003

117. Waade GG, Sanderud A, Hofvind S. Compression force and radiation dose in the Norwegian Breast Cancer Screening Program. Eur J Radiol. 2016;88:41-6. doi:http://dx.doi.org/http://dx.doi.org10.1016/j.ejrad.2016.12.025

118. Weir HK, Anderson RN, Coleman King SM, Soman A, Thompson TD, Hong Y, Moller B, Leadbetter S. Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020. Prev Chronic Dis. 2016;13:E157. doi:http://dx.doi.org/10.5888/pcd13.160211

119. Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ. Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer. 2016;122(6):826-39. doi:http://dx.doi.org/10.1002/cncr.29865